- CA$102.15m
- CA$100.44m
- 42
- 14
- 68
- 36
Annual income statement for Scope AI, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 0 | 0.005 | 0.371 | 3.24 |
Operating Profit | 0 | -0.005 | -0.371 | -3.24 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.075 | -0.005 | -0.369 | -3.21 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.075 | -0.004 | -0.369 | -3.21 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.075 | -0.004 | -0.369 | -3.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.075 | -0.004 | -0.369 | -3.21 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.002 | -0 | -0.01 | -0.065 |
Dividends per Share |